Culture solution and culture method of umbilical cord blood NKT cells
A technology of NKT cells and culture methods, which is applied in the direction of blood/immune system cells, animal cells, vertebrate cells, etc., can solve the problems of weak cell killing activity, low purity of NKT cell content, and low cell expansion rate, etc., to achieve Strong effect of killing tumor cells, conducive to rapid growth, and high rate of killing activity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0093] 1), prepare the first medium, the second medium and the third medium
[0094] The first medium: add CD3 with a final concentration of 300ng / ml, CD137 with a final concentration of 200ng / ml, IL-2 with a final concentration of 2500IU / ml, and a final concentration of 40ng / ml in X-VIVO 15 basal medium IL-15 at a final concentration of 25ng / ml, SCF at a final concentration of 65ng / ml, FGF-2 at a final concentration of 700ug / ml and sodium ferulate at a final concentration of 50ng / ml;
[0095] Second medium: add IL-2 with a final concentration of 1600IU / ml, IL-18 with a final concentration of 20ng / ml, sodium ferulate with a final concentration of 55ng / ml and 550ug / ml in X-VIVO 15 basal medium ml of soybean lecithin;
[0096] The third medium: IL-2 with a final concentration of 1600 IU / ml, sodium ferulate with a final concentration of 55 ng / ml and soybean phospholipid with a final concentration of 550 ug / ml were added to the X-VIVO 15 basal medium.
[0097] 2) Inoculation of ...
Embodiment 2
[0103] 1), prepare the first medium, the second medium and the third medium
[0104] The first medium: KBM581 basal medium was supplemented with CD3 at a final concentration of 200ng / ml, CD137 at a final concentration of 300ng / ml, IL-2 at a final concentration of 3000IU / ml, and IL-2 at a final concentration of 20ng / ml. 15. IL-1β with a final concentration of 20ng / ml, SCF with a final concentration of 50ng / ml, FGF-2 with a final concentration of 600ug / ml and sodium ferulate with a final concentration of 30ng / ml;
[0105] The second medium: KBM581 basal medium was supplemented with IL-2 with a final concentration of 2000IU / ml, IL-18 with a final concentration of 10ng / ml, sodium ferulate with a final concentration of 30ng / ml and soybeans with a final concentration of 300ug / ml Phospholipids;
[0106] The third medium: IL-2 with a final concentration of 2000 IU / ml, sodium ferulate with a final concentration of 30 ng / ml and soybean phospholipid with a final concentration of 300 ug / ...
Embodiment 3
[0113] 1), prepare the first medium, the second medium and the third medium
[0114] The first medium: CD3 with a final concentration of 500ng / ml, CD137 with a final concentration of 100ng / ml, IL-2 with a final concentration of 2000IU / ml, and a final concentration of 50ng / ml were added to the AIM-V basal medium. IL-15, IL-1β with a final concentration of 50ng / ml, SCF with a final concentration of 80ng / ml, FGF-2 with a final concentration of 800ug / ml and sodium ferulate with a final concentration of 80ng / ml;
[0115] Second medium: Add IL-2 with a final concentration of 1000IU / ml, IL-18 with a final concentration of 30ng / ml, sodium ferulate with a final concentration of 80ng / ml and 800ug / ml to the AIM-V basal medium of soybean lecithin;
[0116] The third medium: IL-2 with a final concentration of 1000 IU / ml, sodium ferulate with a final concentration of 80 ng / ml and soybean phospholipid with a final concentration of 800 ug / ml were added to the AIM-V basal medium.
[0117] 2)...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


